Target intelligence / Profile preview

Family with sequence similarity 230 member I (FAM230I)

Target
FAM230I
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA
01

Overview

Family with sequence similarity 230 member I (FAM230I) is a gene encoding a long intergenic non-coding RNA classified as LINC01658. lincRNAs like FAM230I are autonomously transcribed RNA molecules over 200 nucleotides long that do not overlap with protein-coding genes[1][2][4][6]. These RNAs function mainly in the regulation of gene expression, including chromatin architecture remodeling, transcriptional regulation, and genome stability. Although thousands of lincRNAs have been annotated, only a minority have a well-defined role, and FAM230I currently lacks specific functional or disease-related annotation. lincRNAs are essential for fine-tuning gene expression in a tissue- and context-dependent manner but are not generally pharmacological targets[2][4][6]. FAM230I is a non-coding RNA gene, not a protein-coding gene, receptor, or classical therapeutic target, and is most accurately classified under the long intergenic non-coding RNA family[1][2][4][6].

Other names
LINC01658long intergenic non-protein coding RNA 1658FAM230I
02

Mechanism of action

Not applicable

03

Biological functions

Chromatin remodelingTranscription regulationRNA stabilizationFine-tuning expression of neighboring genesOther (potential enhancer-like activity, context-dependent regulation)
04

Disease associations

Other (No confirmed disease association for FAM230I specifically; lincRNAs as a class are implicated in multiple diseases, including cancer, but FAM230I is not currently annotated as directly disease-relevant)

Beyond the preview

Go deeper on Family with sequence similarity 230 member I (FAM230I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 230 member I (FAM230I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call